NASDAQ:BRKR - Bruker Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $37.34 -0.01 (-0.03 %) (As of 02/21/2019 01:20 PM ET)Previous Close$37.35Today's Range$36.85 - $37.4752-Week Range$26.10 - $38.04Volume27,598 shsAverage Volume560,629 shsMarket Capitalization$5.85 billionP/E Ratio26.43Dividend Yield0.43%Beta1.49 ProfileDiscussionAnalyst RatingsChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Bruker Corporation manufactures and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates in two segments, Bruker Scientific Instruments, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry systems; infrared spectroscopy and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection in emergency response, homeland security, and defense applications; and research, analytical, and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies. The company also provides X-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and X-ray metrology, and defect-detection equipment for semiconductor process control, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments and spark optical emission spectroscopy systems. In addition, it offers superconducting and non-superconducting materials and devices. The company serves pharmaceutical, biotechnology and diagnostic, chemical, food and beverage, clinical, polymer, nanotechnology, semiconductor, and industrial companies; nonprofit laboratories; contract research organizations, academic institutions, medical schools, nonprofit or for-profit forensics, agriculture, food and beverage safety, environmental and clinical microbiology laboratories, hospitals, and government departments and agencies; and raw material manufacturers and other businesses through direct sales forces, distributors, independent sales representatives, and other representatives. It has a strategic partnership with Mestrelab Research SL. Bruker Corporation was founded in 1991 and is headquartered in Billerica, Massachusetts. Receive BRKR News and Ratings via Email Sign-up to receive the latest news and ratings for BRKR and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Analytical instruments Sub-IndustryLife Sciences Tools & Services SectorComputer and Technology Current SymbolNASDAQ:BRKR Previous Symbol CUSIP11679410 Webwww.bruker.com Phone978-663-3660Debt Debt-to-Equity Ratio0.27 Current Ratio2.24 Quick Ratio1.32Price-To-Earnings Trailing P/E Ratio26.43 Forward P/E Ratio23.78 P/E Growth2.04 Sales & Book Value Annual Sales$1.90 billion Price / Sales3.08 Cash Flow$1.6493 per share Price / Cash Flow22.64 Book Value$4.72 per share Price / Book7.91Profitability EPS (Most Recent Fiscal Year)$1.40 Net Income$179.70 million Net Margins9.48% Return on Equity27.23% Return on Assets11.83%Miscellaneous Employees6,200 Outstanding Shares156,570,000Market Cap$5.85 billion OptionableOptionable Bruker (NASDAQ:BRKR) Frequently Asked Questions What is Bruker's stock symbol? Bruker trades on the NASDAQ under the ticker symbol "BRKR." How often does Bruker pay dividends? What is the dividend yield for Bruker? Bruker declared a quarterly dividend on Friday, February 15th. Shareholders of record on Tuesday, March 5th will be given a dividend of $0.04 per share on Friday, March 22nd. This represents a $0.16 annualized dividend and a yield of 0.43%. The ex-dividend date is Monday, March 4th. View Bruker's Dividend History. How will Bruker's stock buyback program work? Bruker declared that its Board of Directors has initiated a share repurchase plan on Sunday, June 4th 2017, which authorizes the company to repurchase $225,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to repurchase shares of its stock through open market purchases. Stock repurchase plans are often a sign that the company's board believes its stock is undervalued. How were Bruker's earnings last quarter? Bruker Co. (NASDAQ:BRKR) announced its quarterly earnings data on Monday, February, 11th. The medical research company reported $0.54 EPS for the quarter, meeting the consensus estimate of $0.54. The medical research company had revenue of $553.60 million for the quarter, compared to analysts' expectations of $544.53 million. Bruker had a return on equity of 27.23% and a net margin of 9.48%. View Bruker's Earnings History. When is Bruker's next earnings date? Bruker is scheduled to release their next quarterly earnings announcement on Thursday, May 2nd 2019. View Earnings Estimates for Bruker. What guidance has Bruker issued on next quarter's earnings? Bruker issued an update on its FY 2019 earnings guidance on Monday, February, 11th. The company provided EPS guidance of $1.54-1.58 for the period, compared to the Thomson Reuters consensus estimate of $1.55. The company issued revenue guidance of $2.009-2.028 billion, compared to the consensus revenue estimate of $1.97 billion. What price target have analysts set for BRKR? 5 analysts have issued 12 month price targets for Bruker's shares. Their predictions range from $30.00 to $44.00. On average, they anticipate Bruker's stock price to reach $35.80 in the next twelve months. This suggests that the stock has a possible downside of 4.1%. View Analyst Price Targets for Bruker. What is the consensus analysts' recommendation for Bruker? 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bruker in the last year. There are currently 2 sell ratings, 1 hold rating, 1 buy rating and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Bruker. Has Bruker been receiving favorable news coverage? Media headlines about BRKR stock have been trending somewhat negative recently, InfoTrie reports. InfoTrie ranks the sentiment of media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Bruker earned a media sentiment score of -1.7 on InfoTrie's scale. They also assigned news articles about the medical research company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the company's share price in the next few days. Who are some of Bruker's key competitors? Some companies that are related to Bruker include Waters (WAT), Mettler-Toledo International (MTD), PerkinElmer (PKI), Bio-Rad Laboratories (BIO), Bio-Rad Laboratories (BIO.B), Coherent (COHR), Horiba (HRIBF), Pacific Biosciences of California (PACB), Accelerate Diagnostics (AXDX), Quanterix (QTRX), Fluidigm (FLDM), Eyepoint Pharmaceuticals (EYPT), Harvard Bioscience (HBIO), HTG Molecular Diagnostics (HTGM) and Arrayit (ARYC). Who are Bruker's key executives? Bruker's management team includes the folowing people: Dr. Frank H. Laukien, Chairman, CEO & Pres (Age 58)Dr. Mark R. Munch, Exec. VP and Pres of Bruker Nano Group & Bruker Nano Surfaces Division (Age 56)Mr. Juergen Srega, Pres of Bruker CALID Group & Bruker Daltonics Division (Age 63)Mr. Gerald N. Herman, CFO, VP & Corp. Controller (Age 60)Stacey Desrochers, Treasurer & Director of Investor Relations Who are Bruker's major shareholders? Bruker's stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock Inc. (3.49%), Acadian Asset Management LLC (2.55%), D. E. Shaw & Co. Inc. (1.36%), Bank of America Corp DE (0.86%), Epoch Investment Partners Inc. (0.86%) and Geode Capital Management LLC (0.83%). Company insiders that own Bruker stock include Frank H Laukien, Ingen Chris Van, Mark Munch and Richard Kniss. View Institutional Ownership Trends for Bruker. Which major investors are selling Bruker stock? BRKR stock was sold by a variety of institutional investors in the last quarter, including Acadian Asset Management LLC, BTIM Corp., Prudential Financial Inc., QS Investors LLC, Citigroup Inc., D. E. Shaw & Co. Inc., Bank of Montreal Can and Assenagon Asset Management S.A.. View Insider Buying and Selling for Bruker. Which major investors are buying Bruker stock? BRKR stock was bought by a variety of institutional investors in the last quarter, including First Trust Advisors LP, Thrivent Financial for Lutherans, Bank of America Corp DE, Mackay Shields LLC, Segantii Capital Management Ltd, Millennium Management LLC, Canada Pension Plan Investment Board and Jane Street Group LLC. View Insider Buying and Selling for Bruker. How do I buy shares of Bruker? Shares of BRKR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Bruker's stock price today? One share of BRKR stock can currently be purchased for approximately $37.34. How big of a company is Bruker? Bruker has a market capitalization of $5.85 billion and generates $1.90 billion in revenue each year. The medical research company earns $179.70 million in net income (profit) each year or $1.40 on an earnings per share basis. Bruker employs 6,200 workers across the globe. What is Bruker's official website? The official website for Bruker is http://www.bruker.com. How can I contact Bruker? Bruker's mailing address is 40 Manning Road, Billerica MA, 01821. The medical research company can be reached via phone at 978-663-3660 or via email at [email protected] MarketBeat Community Rating for Bruker (NASDAQ BRKR)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 538 (Vote Outperform)Underperform Votes: 586 (Vote Underperform)Total Votes: 1,124MarketBeat's community ratings are surveys of what our community members think about Bruker and other stocks. Vote "Outperform" if you believe BRKR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BRKR will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/21/2019 by MarketBeat.com StaffFeatured Article: Why are analyst ratings important in trading stocks?